Stay updated on Nivolumab in Advanced Lung Cancer: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Advanced Lung Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Advanced Lung Cancer: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The Nivolumab safety-trial page is available as a full ClinicalTrials.gov study record, with study details, participant criteria, interventions, outcomes, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-07T12:20:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-10-31T12:58:24.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T15:44:53.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-17T15:35:25.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T16:15:57.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record details with a standard error page. This blocks access to the main information about the trial.
    Difference
    17%
    Check dated 2026-09-19T22:05:10.000Z thumbnail image

Stay in the know with updates to Nivolumab in Advanced Lung Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced Lung Cancer: Clinical Trial page.